Announced
Financials
Sources
Tags
Tender Offer
Acquisition
Norway
Majority
Single Bidder
Public
Cross Border
Friendly
Pharmaceuticals
Pending
vitamin production
Synopsis
Lesaffre, a manufacturer of food products, offered to acquire NattoPharma for $75m, a nutraceutical company that develops and sells products containing natural vitamin K2. NattoPharma is in favor of the offer, with its board of directors unanimously deciding to recommend NattoPharma shareholders to accept the voluntary cash offer. “The industrial rationale for a combination of the two companies is substantial, and we regard Lesaffre as an optimal acquirer of the company,” Frode Marc Bohan, NattoPharma Chairman of the Board.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.